Abstract
Physiologically, TTR is mainly acknowledged for being the plasma transporter of thyroxine (T4) and retinol. Under pathological conditions, several mutations in TTR are associated with familial amyloid polyneuropathy (FAP), a neurodegenerative disorder characterized by deposition of TTR amyloid fibrils, particularly in the peripheral nervous system (PNS), where it leads to axonal loss and neuronal death. Although it is well established that TTR synthesis occurs in the liver and in the choroid plexus (the sources of TTR in the plasma and cerebrospinal fluid –CSF, respectively), the origin of TTR deposited in the PNS of FAP patients is unknown. Under physiological conditions TTR has access to the nerve both through the blood and CSF. Additionally, a function for TTR in nerve biology could explain its preferential deposition, when mutated, in the PNS. In this respect, several studies using TTR knockout (KO) mice revealed new TTR functions specifically related to the nervous system: (1) the absence of TTR is associated with reduced signs of depressive-like behavior and with memory impairment; (2) TTR participates in sensorimotor performance; (3) TTR regulates neuropeptide maturation and, (4) TTR enhances nerve regeneration. In the following pages, these novel TTR functions related to the nervous system, as well as the use of TTR KO mice as a means to study them, will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aleshire SL, Bradley CA, Richardson LD, Parl FF (1983) Localization of human prealbumin in choroid plexus epithelium. J Histochem Cytochem 31:608–612
Andrade C (1952) A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75:408–427
Berni R, Malpeli G, Folli C, Murrell JR, Liepnieks JJ, Benson MD (1994) The Ile-84 → Ser amino acid substitution in transthyretin interferes with the interaction with plasma retinol-binding protein. J Biol Chem 269:23395–23398
Billington CJ, Briggs JE, Harker S, Grace M, Levine AS (1994) Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol 266: R1765–R1770
Brouillette J, Quirion R (2007) Transthyretin: a key gene involved in the maintenance of memory capacities during aging. Neurobiol Aging 29:1721–1732
Choi SH, Leight SN, Lee VM, Li T, Wong PC, Johnson JA, Saraiva MJ, Sisodia SS (2007) Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). J Neurosci 27:7006–7010
Costa R, Ferreira-da-Silva F, Saraiva MJ, Cardoso I (2008) Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor. PLoS ONE 3:e2899
Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME, Robertson EJ (1993) Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA 90:2375–2379
Esteban J, Chover AJ, Sanchez PA, Mico JA, Gibert-Rahola J (1989) Central administration of neuropeptide Y induces hypothermia in mice. Possible interaction with central noradrenergic systems. Life Sci 45:2395–2400
Fleming CE, Saraiva MJ, Sousa MM (2007) Transthyretin enhances nerve regeneration. J Neurochem 103:831–839
Fraboulet S, Boudouresque F, Delfino C, Fina F, Oliver C, Ouafik L (1996) Effect of thyroid hormones on peptidylglycine alpha-amidating monooxygenase gene expression in anterior pituitary gland: transcriptional studies and messenger ribonucleic acid stability. Endocrinology 137:5493–5501
Gitlin D, Gitlin JD (1975) Fetal and neonatal development of human plasma proteins. In: Putnam FW (ed) The plasma proteins, Vol II, 2nd edn. Academic Press, New York
Harms PJ, Tu GF, Richardson SJ, Aldred AR, Jaworowski A, Schreiber G (1991) Transthyretin (prealbumin) gene expression in choroid plexus is strongly conserved during evolution of vertebrates. Comp Biochem Physiol B 99:239–249
Heilig M (2004) The NPY system in stress, anxiety and depression. Neuropeptides 38:213–224
Herzog H (2003) Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. Eur J Pharmacol 480:21–29
Inui A, Okita M, Nakajima M, Momose K, Ueno N, Teranishi A, Miura M, Hirosue Y, Sano K, Sato M, Watanabe M, Sakai T, Watanabe T, Ishida K, Silver J, Baba S, Kasuga M (1998) Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y. Proc Assoc Am Physicians 110:171–182
Kotz CM, Briggs JE, Grace MK, Levine AS, Billington CJ (1998) Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat. Am J Physiol 275:R471–R477
Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120:701–713
Liz MA, Sousa MM (2005) Deciphering cryptic proteases. Cell Mol Life Sci 62:989–1002
Monaco HL, Mancia F, Rizzi M, Coda A (1995) Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 268:1039–1041
Liz MA, Faro CJ, Saraiva MJ, Sousa MM (2004) Transthyretin, a new cryptic protease. J Biol Chem 279:21431–21438
Liz MA, Sousa MM (2005) Deciphering cryptic proteases. Cell Mol Life Sci 62:989–1002
Liz MA, Gomes CM, Saraiva MJ, Sousa MM (2007) ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity. J Lipid Res 48:2385–2395
Nunes AF, Saraiva MJ, Sousa MM (2006) Transthyretin knockouts are a new mouse model for increased neuropeptide Y. FASEB J 20:166–168
Palha JA (2002) Transthyretin as a thyroid hormone carrier: function revisited. Clin Chem Lab Med 40:1292–1300
Palha JA, Episkopou V, Maeda S, Shimada K, Gottesman ME, Saraiva MJM (1994) Thyroid hormone metabolism in a transthyretin-null mouse strain. J Biol Chem 269:33135–33139
Palha JA, Hays MT, Morreale de Escobar G, Episkopou V, Gottesman ME, Saraiva MJ (1997) Transthyretin is not essential for thyroxine to reach the brain and other tissues in transthyretin-null mice. Am J Physiol 272:E485–E493
Palha JA, Fernandes R, de Escobar GM, Episkopou V, Gottesman M, Saraiva MJ (2000) Transthyretin regulates thyroid hormone levels in the choroid plexus, but not in the brain parenchyma: study in a transthyretin-null mouse model. Endocrinology 141:3267–3272
Pedrazzini T, Pralong F, Grouzmann E (2003) Neuropeptide Y: the universal soldier. Cell Mol Life Sci 60:350–377
Prigge ST, Mains RE, Eipper BA, Amzel LM (2000) New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell Mol Life Sci 57:1236–1259
Refetoff S, Dwulet FE, Benson MD (1986) Reduced affinity for thyroxine in two of three structural thyroxine-binding prealbumin variants associated with familial amyloidotic polyneuropathy. J Clin Endocrinol Metab 63:1432–1437
Richardson SJ, Bradley AJ, Duan W, Wettenhall RE, Harms PJ, Babon JJ, Southwell BR, Nicol S, Donnellan S, Schreiber G (1994) Evolution of marsupial and other vertebrate thyroxine-binding plasma proteins. Am J Physiol 266:R1359–R1370
Rogers DC, Fisher EM, Brown SD, Peters J, Hunter AJ, Martin JE (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8:711–713
Schreiber G (2002) The evolution of transthyretin synthesis in the choroid plexus. Clin Chem Lab Med 40:1200–1210
Sousa JC, Grandela C, Fernandez-Ruiz J, de Miguel R, de Sousa L, Magalhaes AI, Saraiva MJ, Sousa N, Palha JA (2004a) Transthyretin is involved in depression-like behaviour and exploratory activity. J Neurochem 88:1052–1058
Sousa JC, Marques F, Dias-Ferreira E, Cerqueira JJ, Sousa N, Palha JA (2007) Transthyretin influences spatial reference memory. Neurobiol Learn Mem 88:381–385
Sousa MM, Berglund L, Saraiva MJ (2000) Transthyretin in high density lipoproteins: association with apolipoprotein A-I. J Lipid Res 41:58–65
Sousa MM, Monteiro F, Saraiva MJ (2004b) Lack of amyloid deposition in the peripheral nervous system of transgenic mice expressing human mutant transthyretin in neurons. FENS Abstracts 2:A159.14.
Thiele TE, Marsh DJ, Ste Marie L, Bernstein IL, Palmiter RD (1998) Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396:366–369
Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R, Mathe AA, Heilig M (2000) Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA 97:12852–12857
Wati H, Kawarabayashi T, Matsubara E, Kasai A, Hirasawa T, Kubota T, Harigaya Y, Shoji M, Maeda S (2008) Transthyretin Accelerates Vascular Abeta Deposition in a Mouse Model of Alzheimer's Disease. Brain Pathol. 19:48–57
Wei S, Episkopou V, Piantedosi R, Maeda S, Shimada K, Gottesman ME, Blaner WS (1995) Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination. J Biol Chem 270:866–870
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fleming, C.E., Nunes, A.F., Liz, M.A., Sousa, M.M. (2009). Transthyretin Null Mice as a Model to Study the Involvement of Transthyretin in Neurobiology: From Neuropeptide Processing to Nerve Regeneration. In: Richardson, S.J., Cody, V. (eds) Recent Advances in Transthyretin Evolution, Structure and Biological Functions. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00646-3_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-00646-3_19
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-00645-6
Online ISBN: 978-3-642-00646-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)